Digipath
CHM Cannabis
Home > Boards > US Listed > Biotechs > Eyegate Pharmaceuticals, Inc. (EYEG)

Still here

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Jumpinjackas Member Profile
 
Followed By 22
Posts 3,710
Boards Moderated 0
Alias Born 09/25/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/12/2018 5:25:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/12/2018 4:32:30 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/26/2018 5:10:20 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2018 4:16:55 PM
EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/13/2018 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 7:01:53 AM
EyeGate Pharma Announces Positive Results in Second PRK Study GlobeNewswire Inc. - 11/13/2018 6:55:00 AM
EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study GlobeNewswire Inc. - 11/13/2018 6:55:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 10/24/2018 11:37:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2018 6:59:48 AM
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care GlobeNewswire Inc. - 10/2/2018 6:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2018 7:00:08 AM
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules GlobeNewswire Inc. - 9/25/2018 6:55:00 AM
EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies GlobeNewswire Inc. - 9/24/2018 6:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2018 6:52:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2018 8:36:39 AM
EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies GlobeNewswire Inc. - 9/4/2018 8:31:00 AM
EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis GlobeNewswire Inc. - 9/4/2018 8:30:00 AM
EyeGate Pharmaceuticals Announces Participation at the H.C. Wainwright 20th Annual Global Investment Conference GlobeNewswire Inc. - 8/29/2018 8:30:00 AM
EyeGate Announces Enrollment of First Patient in PRK Pilot Study GlobeNewswire Inc. - 8/20/2018 8:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/10/2018 5:06:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/8/2018 4:19:50 PM
EyeGate Pharmaceuticals Announces New Board Member, Peter Greenleaf GlobeNewswire Inc. - 8/7/2018 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/3/2018 8:35:09 AM
EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire Inc. - 8/3/2018 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist